Access cutting-edge absence epilepsy treatment through this clinical trial at a research site in Tampa. Study-provided care at no cost to qualified participants.
Access absence epilepsy specialists in Tampa at no cost
This study follows strict safety protocols and ethical guidelines
All study-related absence epilepsy treatment provided free
The purpose of the study is to test the efficacy, safety and tolerability of brivaracetam monotherapy in study participants 2 to 25 years of age inclusive with childhood absence epilepsy (CAE) or juvenile absence epilepsy (JAE).
Sponsor: UCB Biopharma SRL
Check if you qualify for this absence epilepsy clinical trial in Tampa, FL
If you're searching for absence epilepsy treatment options in Tampa, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tampa research site is actively enrolling participants for this clinical trial. You'll receive care from experienced absence epilepsy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.